Immunotherapy for osteosarcoma

di Yahiro, Kenichiro, Matsumoto, Yoshihiro
Pubblicato in Hum Vaccin Immunother (2020)

Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line

di Yahiro, Kenichiro, Matsumoto, Yoshihiro, Fukushi, Jun-ichi, Kawaguchi, Ken-ichi, Endo, Makoto, Setsu, Nokitaka, IIda, Keiichiro, Fukushima, Suguru, Nakagawa, Makoto, Kimura, Atsushi, Oda, Yoshinao, Nakashima, Yasuharu
Pubblicato in Anal Cell Pathol (Amst) (2018)

Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor

di Fukushima, Suguru, Endo, Makoto, Matsumoto, Yoshihiro, Fukushi, Jun-ichi, Matsunobu, Tomoya, Kawaguchi, Ken-ichi, Setsu, Nokitaka, IIda, Keiichiro, Yokoyama, Nobuhiko, Nakagawa, Makoto, Yahiro, Kenichiro, Oda, Yoshinao, Iwamoto, Yukihide, Nakashima, Yasuharu
Pubblicato in PLoS One (2017)

Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor

di Fukushima, Suguru, Endo, Makoto, Matsumoto, Yoshihiro, Fukushi, Jun-ichi, Matsunobu, Tomoya, Kawaguchi, Ken-ichi, Setsu, Nokitaka, IIda, Keiichiro, Yokoyama, Nobuhiko, Nakagawa, Makoto, Yahiro, Kenichiro, Oda, Yoshinao, Iwamoto, Yukihide, Nakashima, Yasuharu
Pubblicato in PLoS One (2018)